Cannabis Earnings

Decibel Reports Q1 Record Net Revenue And Adjusted EBITDA, Here Are The Details

Decibel Reports Q1 Record Net Revenue And Adjusted EBITDA, Here Are The Details

Verano Q1 Revenue Improves 67% YoY, What About Net Loss?

Verano Q1 Revenue Improves 67% YoY, What About Net Loss?

Jushi Q1 Revenue Grows 48.5% YoY, Revises 2022 Revenue And EBITDA Guidance

Jushi Q1 Revenue Grows 48.5% YoY, Revises 2022 Revenue And EBITDA Guidance

Marijuana Company Of America Revenue In Q1 2022 Grows 1507% YoY, Here Is How

Marijuana Company Of America Revenue In Q1 2022 Grows 1507% YoY, Here Is How

Rubicon Organics Q1 Revenue Grows 25% YoY, Confirms Guidance On Positive Adjusted EBITDA

Rubicon Organics Q1 Revenue Grows 25% YoY, Confirms Guidance On Positive Adjusted EBITDA

4Front Ventures Reports Q1 2022 Financial Results, Declines 8% Sequentially To $26.1M, CEO Optimistic

4Front Ventures Reports Q1 2022 Financial Results, Declines 8% Sequentially To $26.1M, CEO Optimistic

The Flowr Corp. Revenue Grows 64% In 2021, Achieves Record Quarterly Revenue Thanks To This

The Flowr Corp. Revenue Grows 64% In 2021, Achieves Record Quarterly Revenue Thanks To This

Acreage Holdings Is An Arbitrage Play, This Analyst Explains Why

Acreage Holdings Is An Arbitrage Play, This Analyst Explains Why

Indiva Announces Q1 Revenue Grows 43.8%, Here Are The Details

Indiva Announces Q1 Revenue Grows 43.8%, Here Are The Details

Here's Why Investors Should Keep An Eye On Sundial Stock, Analyst's Thoughts Post Q1 Earnings

Here's Why Investors Should Keep An Eye On Sundial Stock, Analyst's Thoughts Post Q1 Earnings

Cresco Labs Q1 Revenue Grows 20%, Here Are The Details

Cresco Labs Q1 Revenue Grows 20%, Here Are The Details

Kaya Reports Unaudited Revenue Of $741K For First Four Months Of 2022, Positive Adjusted EBIDTA For April

Kaya Reports Unaudited Revenue Of $741K For First Four Months Of 2022, Positive Adjusted EBIDTA For April

This Cannabis Vape Market Leader Is Feeling Impact Of Price Competition, Analyst's Thoughts Post Q1 Earnings

This Cannabis Vape Market Leader Is Feeling Impact Of Price Competition, Analyst's Thoughts Post Q1 Earnings

Trees Q1 Revenue Grows 225% YoY, Reduces Corporate Debt

Trees Q1 Revenue Grows 225% YoY, Reduces Corporate Debt

Halo Collective Q1 2022 Revenue Slightly Drops, Announces Significant Reductions

Halo Collective Q1 2022 Revenue Slightly Drops, Announces Significant Reductions

New Jersey Sen. Turner Presents Bill To Add Blood Testing For Driving While Cannabis-Intoxicated

New Jersey Sen. Turner Presents Bill To Add Blood Testing For Driving While Cannabis-Intoxicated

Greenlane Q1 Revenue Rescued From Decline By KushCo Merger, Here Are The Details

Greenlane Q1 Revenue Rescued From Decline By KushCo Merger, Here Are The Details

Schwazze Q1 Revenue Up 20% Sequentially To $31.8M, Retail Sales Increased 124% To $26.5M

Schwazze Q1 Revenue Up 20% Sequentially To $31.8M, Retail Sales Increased 124% To $26.5M

TILT Holdings Q1 Revenue Down 22% Sequentially To $42.4M, $55 Million In Leaseback Transaction

TILT Holdings Q1 Revenue Down 22% Sequentially To $42.4M, $55 Million In Leaseback Transaction

Columbia Care: Challenging 1Q, Stock Is Now Tied to Cresco Deal Analyst Says

Columbia Care: Challenging 1Q, Stock Is Now Tied to Cresco Deal Analyst Says

Charlotte's Web Delivers Operating Improvements On Lower Revenue In First Quarter 2022

Charlotte's Web Delivers Operating Improvements On Lower Revenue In First Quarter 2022

Unrivaled Brands Q1 Revenue Decreases 9% Sequentially To $20.7 Million

Unrivaled Brands Q1 Revenue Decreases 9% Sequentially To $20.7 Million

Planet 13 Announces Q1 2022 Financial Results, Revenue Up 8% To $25.7M

Planet 13 Announces Q1 2022 Financial Results, Revenue Up 8% To $25.7M

MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year

MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year

Cannabis Wellness Company OMID's Unaudited Results For Q1 Show Solid Revenue Growth

Cannabis Wellness Company OMID's Unaudited Results For Q1 Show Solid Revenue Growth

CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share

CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share

Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details

Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details

Delta 9 Cannabis Q1 Revenue Slightly Declines YoY, Reports Adjusted EBITDA Loss

Delta 9 Cannabis Q1 Revenue Slightly Declines YoY, Reports Adjusted EBITDA Loss

MediPharm Labs Q1 Revenue Slightly Drops, Here Are The Details

MediPharm Labs Q1 Revenue Slightly Drops, Here Are The Details

Axuly Q1 Revenue Improves 147% YoY To CA$22.6M, Here Is Why

Axuly Q1 Revenue Improves 147% YoY To CA$22.6M, Here Is Why